16 Minutes News by a16z

CRISPR! Policy, Platform, Trials (#11)

av 16 Minutes News by a16z | Publicerades 10/8/2019

News and trends covered this week -- all about the latest policy and in practice implication for CRISPR -- include: * California law requiring labels for self-editing kits (that don't exist yet) * Alliance (including 13 of the most active companies in gene editing for therapeutics) statement against germline editing at this time -- and parallels/differences given China CRISPR babies scandal & recombinant DNA from 1970s * clinical trials for CRISPR come of age, with first publicly identified patient (for sickle cell disease) and first study inside the human body (for inherited congenital blindness) * CRISPR as a platform, applications, and what all of this means for innovation …with @jorgecondebio @andy23tran and host @smc90.

Om Podcasten

Introducing our new podcast, 16 Minutes, a short news podcast where we cover the top headlines of the week, the a16z podcast way -- why are these topics in the news; what's real, what's hype from our vantage point; and what are our experts' quick takes on these trends? About the a16z Podcast: Discusses tech and culture trends, news, and the future -- especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This podcast is produced by Andreessen Horowitz (aka “a16z”), a Silicon Valley-based venture capital firm. Multiple episodes -- and now shows -- are released every week; visit a16z.com for more details and to sign up for our newsletters and other content as well!